The aim of this study was finding out the rates of pneumococcal and influenza vaccination, the factors influencing vaccination, and non-vaccination in COPD patients.The study was conducted with 104 COPD patients diagnosed by a pulmonologist. The diagnosis was made according to the GOLD 2019 document via an FEV1/FVC ratio below 70%. The patients were inquired about getting vaccinated for influenza in the last year and pneumococci in the last five years. The patients were then grouped according to their vaccination status and inquired about their perception of the necessity of vaccination. The study revealed a significant association between COPD levels and the awareness of the necessity of annual influenza vaccination (p=0.019). However, there was no significant association between COPD levels and being vaccinated for influenza in the last year (p=0.434). There was no significant association between COPD levels and pneumococcal vaccination in the last five years or the awareness for the necessity of the vaccine (p=0.0559 and p=0.495). 22.2% of the patients who were vaccinated for pneumonia were also vaccinated for influenza and 98.7% of the patients who were not vaccinated for pneumonia were also not vaccinated for influenza in the last year. 85.7% of the patients who got an influenza vaccine in the last year also knew the necessity of getting annually vaccinated (p=
1. Global Strategy for the Diagnosis, Management and Prevention of COPD, Global Initiative for Chronic Obstructive Lung Disease (GOLD) 2019.
2. Zwaans WA, Mallia P, van Winden ME, et al. The relevance of respiratory viral infections in the exacerbations of chronic obstructive pulmonary disease—a systematic review. J Clin Virol. 2014;61:181-8.
3. Song JY, Nahm MH, Cheong HJ, et al. Impact of preceding flu-like illness on the serotype distribution of pneumococcal pneumonia. PLoS One. 2014;9:e93477.
4. Donner CF. Infectious exacerbations of chronic bronchitis. Monaldi Arch Chest Dis. 1999;54:43-8.
5. Erer OF, Karadeniz G, Gazibaba D ve ark. Kronik obstrüktif akciğer has¬talığında aşılanma; gerçekten yaptırtıyor muyuz? İzmir Göğüs Hastanesi Dergisi. 2013;25:31-40.
6. Uçar N, Akpınar S, Yıldız M, Şipit T.KOAH’lı Olgularda ı̇nfluenza ve pnömokok aşısı olma sıklığı. Solunum Hastalıkları. 2015;25:1-4
7. Özsu S, Uçar E, Arslan Y ve ark. KOAH hastalarında influenza ve pnömokok aşılanma sıklığı. Solunum. 2011;13:21-5.
8. Schembri S, Morant S, Winter JH, et al. Influenza but not pneumoncoccal vaccination protects againts all-cause mortality in patients with COPD: Thorax. 2009;64:567-72.
9. CDC. Influenza and pneumococcalvaccination coverage among persons aged >65 YearsUnited States, 2004-2005. Morb Mortal Wkly Rep. 2006;55:1065-8.
10. Egbert N, Nanna KM. Health Literacy: Challenges and Strategies. OJIN. 2009;14:1-9.
11. Balbay EG, Tanrıverdi E, Alaşan F, ve ark. Düzce ı̇linde kronik obstrüktif akciğer hastalığı tanılı hastaların aşılanma sıklığı. Düzce Üniversitesi Sağlık Bilimleri Enstitüsü Dergisi. 2013;3:15-17.
12. Schoefer Y, Schaberg T, Raspe H, et al. Determinants of influenza and pneumococcal vaccination in patients with chronic lung diseases. J Infect. 2007;55:347-52.
13. Szucs TD, Muller D. Influenza vaccination coverage rates in five European countries-a population-based cross-sectional analysis of two consecutive influenza seasons. Vaccine. 2005;23:5055-63.
14. Schwartz KL, Neale AV, Northrup J, et al. Racial similarities to standardized offer of influenza vaccination: a metronet study. JGen Intern Med. 2006;21:346–51.
15. Özlü T, Bülbül Y, Alataş F, et al. Türk Toraks Derneği erişkinlerde toplumda gelişen pnömoni tanı ve tedavi uzlaşı raporu. Türk Toraks Dergisi. 2009;10:5–9 (article i n Turkish)
16. Walters JA, Smith S, Poole P, vd. Kronik obstrüktif akciğer hastalığı olan hastalarda pnömokok enfeksiyonunu önlemek için enjekte edilebilir aşılar. Cochrane Database Syst Rev. 2010;11:CD001390.
17. Sethi S, Murphy T. Patogenezinde enfeksiyon ve kronik obstrüktif akciğer hastalığının seyri. N Engl J Med. 2008;359:2355-65.
18. Jimenez-Garcia R, Arinez-Fernandez MC, Hernandez-Barrera V, Garcia-Carballo MM, Miguel AG, Carrasco-Garrido P. Compliance with influenza and pneumococcal vaccination among patients with chronic obstructive pulmonary disease consulting their medical practitioners in Catalonia, Spain. J Infect. 2007;54:65-74.
19. Christenson B, Lundbergh P. Comparison between cohorts vaccinated and unvaccinated against influenza and pneumococcal infection. Epidemiol Infect. 2002;129:515-24.
20. Froes F, Roche N, Blasi Francesco. Pneumococcal vaccination and chronic respiratory diseases.Int J Chron Obstruct Pulmon Dis. 2017;12:3457–68.
21. Ipsos PneuVUE: a new view into pneumonia among older adults. 2016
22. Bovier PA, Chamot E, Bouvier GM, Loutan L. Importance of patients’ perceptions and general practitioners’ recommendations in understanding missed opportunities for immunisations in Swiss adults. Vaccine. 2001;19:4760-7.
23. Kamal KM, Madhavan SS, Amonkar MM. Determinants of adult influenza and pneumonia immunization rates. J Am Pharm Assoc. 2003;43:403-11.
24. Jimenez- Garcia R, Arinez-Fernandez MC, Garcia-Carballo M, et al. Influenza vaccination coverage and related factors among Spanish patients with chronic obstructive pulmonary diseases. Vaccine. 2005;23:3679-86.
25. Bülbül Y, Öztuna F, Gülsoy F, Özlü T. Doğu Karadeniz Bölgesinde Kronik Obstrüktif Akciğer Hastalığı; hastalık özellikleri ve İnfuenza-Pnömokok aşılama sıklığı. Türkiye Klinikleri J Med Sci. 2010;30:24-9.
26. Ariñez-Fernandez MC, Carrasco-Garrido P, Garcia-Carballo M, Hernández-Barrera V, de Miguel AG, Jiménez-García R, et al. Determinants of pneumococcal vaccination among patients with chronic obstructive pulmonary disease in Spain. Hum Vaccin. 2006;2:99–104.
27. Filipe Froes, 1 Nicolas Roche , 2 ve Francesco Blasi 3, Pneumococcal vaccination and chronic respiratory diseases.Int J Chron Obstruct Pulmon Dis. 2017;12:3457–68.